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Abstract:
Introduction: Controlled prescription opioid use is perceived as a national problem attributed
to all specialties. Our objective was to provide a descriptive analysis of prescriptions written for
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controlled opioids from a database of emergency department (ED) visits prior to the enactment
of the I-STOP law, which requires New York prescribers to consult the Prescription Monitoring
Program (PMP) prior to prescribing Schedule II, III, and IV controlled substances for prescriptions
of greater than five days duration.
Methods: We conducted a retrospective medical record review of patients 21 years of age and
older, who presented to the ED between July 1, 2011 – June 30, 2012 and were given a prescription
for a controlled opioid. Our primary purpose was to characterize each prescription as to the type of
controlled substance, the quantity dispensed, and the duration of the prescription. We also looked
at outliers, those patients who received prescriptions for longer than five days.
Results: A total of 9,502 prescriptions were written for opioids out of a total 63,143 prescriptions
for 69,500 adult patients. Twenty-six (0.27%) of the prescriptions for controlled opioids were written
for greater than five days. Most prescriptions were for five days or less (99.7%, 95% CI [99.6 to
99.8%]).
Conclusion: The vast majority of opioid prescriptions in our ED prior to the I-STOP legislature
were limited to a five-day or less supply. These new regulations were meant to reduce the
ED’s contribution to the rise of opioid related morbidity. This study suggests that the emergency
physicians’ usual prescribing practices were negligibly limited by the new restrictive regulations.
The ED may not be primarily contributing to the increase in opioid-related overdoses and death.
The effect of the I-STOP regulation on future prescribing patterns in the ED remains to be
determined. [West J Emerg Med. 2015;16(1):–0.]
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Introduction: Controlled prescription opioid use is perceived as a national problem attributed
to all specialties. Our objective was to provide a descriptive analysis of prescriptions written for
controlled opioids from a database of emergency department (ED) visits prior to the enactment
of the I-STOP law, which requires New York prescribers to consult the Prescription Monitoring
Program (PMP) prior to prescribing Schedule II, III, and IV controlled substances for prescriptions
of greater than five days duration.
Methods: We conducted a retrospective medical record review of patients 21 years of age and
older, who presented to the ED between July 1, 2011 – June 30, 2012 and were given a prescription
for a controlled opioid. Our primary purpose was to characterize each prescription as to the type of
controlled substance, the quantity dispensed, and the duration of the prescription. We also looked at
outliers, those patients who received prescriptions for longer than five days.
Results: A total of 9,502 prescriptions were written for opioids out of a total 63,143 prescriptions for
69,500 adult patients. Twenty-six (0.27%) of the prescriptions for controlled opioids were written for
greater than five days. Most prescriptions were for five days or less (99.7%, 95% CI [99.6 to 99.8%]).
Conclusion: The vast majority of opioid prescriptions in our ED prior to the I-STOP legislature
were limited to a five-day or less supply. These new regulations were meant to reduce the ED’s
contribution to the rise of opioid related morbidity. This study suggests that the emergency
physicians’ usual prescribing practices were negligibly limited by the new restrictive regulations. The
ED may not be primarily contributing to the increase in opioid-related overdoses and death. The
effect of the I-STOP regulation on future prescribing patterns in the ED remains to be determined.
[West J Emerg Med. 2015;16(1):62–66.]

INTRODUCTION
Pain is one of the most common chief complaints treated
in the emergency department (ED), and for many years
there has been a strong emphasis on addressing adequate
pain control.1 Despite the increased importance placed on
providing appropriate analgesia, emergency physicians (EP)
Western Journal of Emergency Medicine

continue to provide inadequate pain management.2 This
practice may be related to the clinician’s awareness of the
significant problems with drug dependence in the United
States. There is an increase in the abuse of prescription
drugs, specifically oxycodone and hydrocodone, and it far
exceeds the increases in abuse of illicit substances, including
62
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marijuana, cocaine, and heroin.2
Even with attempts to reduce narcotic abuse and
addiction, people continue to exhibit violent behaviors
to obtain narcotics. Violent acts led the New York State
Legislature to introduce a bill that enhanced the effectiveness
of New York’s existing Prescription Monitoring Program
(PMP) with the intention of reducing drug diversion.3 “The
Internet System for Tracking Over-Prescribing (I-STOP)
Act” established an online, real-time controlled substance
reporting system that mandates physicians and pharmacists
to search for and report certain data at the time a schedule
II, III, IV, or V controlled substance prescription is issued
and at the time such substance is dispensed.”4 It took effect
in August of 2013. In New York, EPs are waived from the
mandatory consultation of the PMP for prescriptions written
for five days or less.
There is an association between the maximum prescribed
daily dose by any physician and opioid overdose-related
deaths, with higher opioid doses related to an increased risk
of an opioid overdose death.5-13Although multiple studies
track the number of prescriptions written by EPs over a period
of time, our literature search found no articles that examine
the quantity of opioids prescribed to each individual patient
during one visit. The duration of pain medications were not
included in these particular studies.
We designed this descriptive study to assess the
prescription patterns of EPs for opioids prior to the enactment
of the New York I-STOP act in a single academic community
ED on Long Island. Our expectation is that EPs had been
prescribing no more than five days of controlled opioids even
before the creation of the new legislation.

order entry system enables the collection of standardized
information for each patient and integrates that information
into a relational database and also has the advantage
of generating prescriptions that were included in the
medical record. The database was queried by SQL Cognos
Impromptu™ (Cognos), which allows the administrator
to create reports using criteria filters. Using the inclusion
criteria, a report was created with Cognos that queried
all patients seen in the ED who fit the criteria for study
enrollment. This report was further analyzed by Microsoft
Excel 2007. This method has been used and described in
other studies.14-16
The prescriptions analyzed were those written for
opioids including hydrocodone, morphine, hydromorphone,
and fentanyl (patches) as seen in Table 1. Tramadol was not
analyzed, as it only has been considered a controlled substance
in New York since August 27, 2012. We also excluded a
cough syrup containing hydrocodone with homatropine in low
dose (Hycodan®) because it was never prescribed in amounts
of more than 120mL, which was equivalent to the total
hydrocodone of 24 pills (a quantity usually of no more than
five days as traditionally prescribed), and we could find little
evidence for this significantly contributing to the epidemic of
prescription drug abuse overdoses or deaths.
We calculated the number of days prescribed by using
the number of doses prescribed, shortest recommended
dosing frequency and converting this to the number of
days the prescription would last (Figure 1). All patient
charts that had a prescription of more than five days were
manually reviewed.
RESULTS
A total of 63,143 prescriptions were written between
July 1, 2011 and June 30, 2012. The demographics are listed
in Table 2. Of those prescriptions, 9,502 prescriptions were
written for opioids. We excluded 71 prescriptions from the
study because they were duplicates of the original prescription
or lacking information on the prescription to calculate the
number of days. Of the 9,502 prescriptions written that
were included in our study, 99.7% already complied with
the new regulations (95% CI [99.6 to 99.8%]). Twenty-six
prescriptions (0.27%) were written for greater than five days
as seen in Figure 2. Some were a result of larger intervals
between each dose than typically recommended. For example,

METHODS
This was a retrospective chart review to analyze the
prescriptions for controlled opioids prior to the enactment
of the I-STOP law. The study was conducted at a suburban
academic community hospital ED with an annual census of
approximately 95,000 patients. All patients older than 21 years
are seen in an adult ED area (69,500).
The database search included all patients 21 and older
who received a prescription for a controlled opioid at
discharge between the dates of July 1, 2011 and June 30,
2012. We characterized each prescription as to the type of
controlled opioid, the quantity dispensed, and the length of
time for the prescription. Medical records with insufficient
or inconsistent time stamps and/or other entries and patients
who left prior to formal discharge were excluded. The
data extracted included the following: hospital account
number, age, sex, ethnicity, diagnosis, arrival date, time, and
prescriptions written.
We abstracted the data from the electronic medical
record (Allscripts ED™ - formerly Healthmatics A4™)
for patients discharged from the ED with one or more
prescriptions. This computerized patient charting and
Volume XVI, NO. 1 : January 2015

Table 1. Percentage of opioid prescriptions written.
Opioids (n)
Oxycodone

84.08% (8040)

Hydrocodone

14.47% (1324)

Morphine
Hydromorphone
Fentanyl

63

% (No.) of prescriptions

0.02% (2)
1.24% (119)
0.18% (17)
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Figure 1. Analysis of prescriptions written in the emergency department.
*The prescriptions that were excluded as listed in the methods section include those written for patients who are less than 21 or have a
malignancy and chronic inflammatory disease. Patients who also received Hycodan® were also excluded.

fentanyl usually is packaged in a box of five patches and each
patch is used for three days at a time. The prescriptions written
for greater than five days were categorized by diagnosis.
A breakdown of the 26 outlying prescriptions and related
diagnoses are provided in Figure 2 with their corresponding
diagnoses. All written opioid prescriptions were further
divided by the number of days they were written for, which is
seen in Figure 3.
Our study found that prescriptions for opioids were
usually for no more than five days in length and would have
almost always complied with the new state regulations.

Table 2. Demographics of patients receiving opioid versus nonopioid prescriptions.
Opioid
N
Mean age, y (SD)

All prescription

9,502

28,621

44.9 (15.2)

44 (16.4)

Male (%)

42.8%

43.2%

White (%)

61.2%

61.5%

DISCUSSION
I-STOP made New York the first state in the nation to
mandate that physicians consult a database of a patient’s
prescription history before prescribing a schedule II, III, or IV
controlled substance.17 Studies analyzing the impact of PMPs
have been unanimous in regards to decreasing drug dependence
and diversion by inhibiting growth in prescription sales for
pain relievers. This act may further enhance the PMP’s goal;
however, it can be hindering in an emergency setting. There is
ongoing concern about EPs undertreating pain and the majority
of emergency patients suffering from acute injury.
In the ED, pain management continues to be a
significant complaint requiring practitioner attention as
seen from the data of this study where approximately onesixth of all prescriptions written were for opioid analgesics.
As seen in numerous studies conducted previously,
oxycodone continues to be the most commonly prescribed

Figure 2. Diagnosis of patients receiving opioid prescriptions for
greater than 5 days (n=26).

Western Journal of Emergency Medicine
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prescriptions for acute pain and promulgate oligoanalgesia.
LIMITATIONS
Our study has several limitations. It was a retrospective
study and has all the limitation therein. It was completed
at a single suburban academic community hospital ED
and therefore might not represent other communities or
institutions. It cannot determine if the patient is “doctorshopping” and visiting other EDs, doctors’ offices, or even
the same ED but on subsequent days or weeks. We focused
on the duration of opioid prescriptions written rather than the
maximum concentration of the opioid all together or total per
day. There is increased risk of overdose in patients receiving
medically prescribed opioids at higher doses.5-13
Patients can still “doctor-shop,” and if an EP does not
have a clinical suspicion for substance abuse, the small
amounts of opioids given can supply an addiction from
multiple sources. Furthermore, a patient’s inability to obtain
a sufficient quantity of prescription opioids may lead them to
solicit street drugs that have unregulated compositions adding
to potentially worse adverse outcomes.
The study did not provide any data on the type of
pain or response to initial treatment. It was not designed
to determine whether pain was adequately treated. The
results could be influenced by variations in individual
provider practice, and the study did not control for the effect
of clustering by individual providers. Providers in this
department see patients on a next patient basis and do not
choose the next patient to be seen, thus minimizing this type
of selection bias.
Whether the implementation of this regulation will change
the prescribing practices of physicians is not known and
would be an interesting question to pursue.

Figure 3. Breadkdown of opioid prescriptions into the number of
days they were written for.

opioid (84%).15,18-20 We were able to illustrate that in a
large suburban, community ED, most physicians were
prescribing five days or less worth of prescriptions for
opioids, with the majority being for three days or less. This
pattern could be affected by the presence of an electronic
medical record (EMR) that has prebuilt prescriptions for
a set number of pills. Even though prescriptions could be
typed up individually with varying dosing and number of
pills, it might be more efficient for a physician to select a
prebuilt prescription.
Of the opioids considered in this study, short-acting
oxycodone is still the most commonly prescribed opioid
as well as the most commonly prescribed for greater than
five days. The small number of patients who received
more than five days’ worth of opioids had pain from acute
musculoskeletal injuries, chronic low back pain, herniated
disc, and diabetic neuropathy.
Giving ED physicians the privilege of providing opioid
pain relievers without referring to the PMP permits them to
function effectively in their environment. Our study shows
that the EP already displays independent responsibility in
opioid prescribing patterns. The PMP in theory may add little
to reduce the amount of drug overdoses in the ED setting.
Prior to enactment of this legislation, EPs had not been
giving prescriptions of opioids that were excessive and therefore
not likely to be contributing to the rise of opioid overdoses
and deaths in the community. Further regulations requiring
the additional step of consulting a database before prescribing
controlled opioids may have the potential to inhibit opioid
Volume XVI, NO. 1 : January 2015

CONCLUSION
The duration of opioids prescribed from one ED visit
in this suburban, community Long Island ED prior to the
I-STOP legislature was largely limited to five days or less.
This suggests that EPs had been largely abiding with the
spirit of the new bill prior to its drafting. Although the PMP
might assist with abuse and dependency of opioids in this
community, it remains unknown whether this will impact
optimal prescribing practices for pain.
Address for Correspondence: Lyncean Ung, DO, Good Samaritan
Hospital Medical Center, 1000 Montauk Hwy, West Islip, NY 11795.
Email: lyncean.ung@gmail.com.
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